StockNews.AI
ENFN
StockNews.AI
169 days

Enfusion Announces Fourth Quarter and Full Year 2024 Results

1. Enfusion reported $52.9 million in Q4 revenue, a 13.9% increase. 2. Gross profit margin reached 69% with solid financial performance.

Earnings
+0.26%Current Return
VS
-1.2%S&P 500
$11.3703/03 04:19 PM EDTEvent Start
$11.403/04 10:18 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

The earnings growth and stable gross margin suggest a strong market position. Strong Q4 performance often encourages investor confidence.

How important is it?

The reported revenue growth directly suggests potential stock price appreciation, particularly for earnings-responsive investors.

Why Short Term?

Immediate investor reactions to earnings results typically influence stock prices strongly soon after reporting.

Related Companies

MSCIBLKTROW
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights: Total revenue was $52.9 million, up 13.9% compared to the same period in the prior year. Gross Profit was $36.5 million with a Gross Profit Margin of 69.0%. Adjusted Gross Profit was $3.

Related News